The state of pharma’s chief marketing officers part 2: Being an ‘innovation catalyst’ for creativity
In the not too distant past, pharma lagged behind consumer advertising’s ability to churn out cutting-edge creativity. Weighed down by the regulatory, safety and compliance aspects that are par for ...
As a relatively new role in pharma — and one that not all pharma companies have — chief marketing officers (CMOs) are tasked with raising the profile of marketing within their companies and driving ...
OptimizeRx Corporation is evolving from an EHR messaging platform to a clinical data and AI-driven advertising company, leveraging DAAP and MNT technologies. Q2 2025 financials show strong revenue ...
Arcane™ – A generative AI tool that solves pharma's content discovery, reuse, and creation challenges. It reduces costs, removes complexity, and accelerates content production. Activator™ – A content ...
If only 13% of consumers strongly believe brands provide accurate information, how do pharma companies connect with increasingly discerning patients and healthcare professionals? That’s a key ...
Morning Hubsters. John R Fischer here with the US Wire from the New York newsroom. Pharmaceutical companies are spending more on marketing than ever before, driven by factors including the aging of ...
Mistargeted and irrelevant ads plague the TV viewing experience. Pharma brands struggle with targeting and measurement because patient data is highly regulated. A web of national laws, namely HIPAA, ...
The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Maria Alonso In the ...
Doximity is experiencing strong user engagement growth, driven by demand from medical prescribers and pharmaceutical marketers. Pharma marketing, Doximity's largest opportunity, is fueling sustained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results